Targeting acetaldehyde dehydrogenase 2 (ALDH2) in heart failure-Recent insights and perspectives - PubMed (original) (raw)

Review

. 2017 Aug;1863(8):1933-1941.

doi: 10.1016/j.bbadis.2016.10.004. Epub 2016 Oct 11.

Affiliations

Free article

Review

Targeting acetaldehyde dehydrogenase 2 (ALDH2) in heart failure-Recent insights and perspectives

Jiaojiao Pang et al. Biochim Biophys Acta Mol Basis Dis. 2017 Aug.

Free article

Abstract

Heart failure is one of the major causes of the ever-rising mortality globally. ALDH2 rs671 polymorphism is proven to be closely related to the prevalence of CAD, hypertension, diabetes mellitus and alcoholism, which are etiological factors of heart failure. In addition, growing evidence supports a possible role for ALDH2 in different forms of heart failure. In this mini-review, we will review the recent insights regarding the effects of ALDH2 polymorphism on etiological factors of heart failure and underlying mechanisms involved. In addition, we will also discuss the booming epigenetic information in this field which will greatly improve our understanding of the cardiovascular effect of ALDH2. This article is part of a Special Issue entitled: Genetic and epigenetic control of heart failure edited by Dr. Jun Ren & Yingmei Zhang.

Keywords: ALDH2; Epigenetic regulation; Genetic polymorphism; Heart failure.

Copyright © 2016 Elsevier B.V. All rights reserved.

PubMed Disclaimer

Publication types

MeSH terms

Substances

LinkOut - more resources